2016: The Year of Diversity in Clinical Trials

2016: The Year of Diversity in Clinical Trials
By: Robert M. Califf, M.D.

Controlled clinical trials provide a critical base of evidence for evaluating whether a medical product is effective before the product is approved for marketing. One challenge that remains for FDA is ensuring that research participants...

Read the Voice Blog

More on FDASIA 907 and Clinical Trials 

Progress and Collaboration on Clinical Trials

FDASIA 907: Inclusion of Demographic Subgroups in Clinical Trials

Action Plan to Enhance the Collection and Availability of Demographic Subgroup Data